Neuroxt
South Korea
NeuroXT Inc. is an innovative AI company that specializes in redefining brain imaging through advanced MRI-based technology. The company aims to enhance neurodegenerative care by providing leading MRI-based AI solutions that assist in diagnosis and treatment decisions without relying on PET scans. NeuroXT has developed a world-first multimodal platform designed to measure in-vivo synaptic integrity, enabling researchers to objectively verify the effectiveness of synapse-targeted therapies. Their NEXT-STAGE product leverages routine MRI to infer regional tau burden in a non-invasive, scalable, and cost-effective manner, making it an invaluable tool for biopharma research teams and academic hospitals.
Only accessible to MedStartr community members.
Join nowCompany Info
- Website
- www.neuroxt.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Neuroxt?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now